The role of intraperitoneal chemotherapy in epithelial ovarian cancer
- 1 January 2000
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 10 (s1) , 26-32
- https://doi.org/10.1046/j.1525-1438.2000.99507.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1998
- Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual diseaseAnnals of Oncology, 1997
- Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian CancerNew England Journal of Medicine, 1996
- A Comparison of Intravenous versus Intraperitoneal Chemotherapy for the Initial Treatment of Ovarian CancerGynecologic Oncology, 1994
- Evidence Supporting the Superiority of Intraperitoneal Cisplatin Compared to Intraperitoneal Carboplatin for Salvage Therapy of Small-Volume Residual Ovarian CancerGynecologic Oncology, 1993
- Long-term survival in ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.BMJ, 1991
- Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapyCancer Chemotherapy and Pharmacology, 1991
- Effect of Sodium Thiosulfate on the Pharmacokinetics and Toxicity of CisplatinJNCI Journal of the National Cancer Institute, 1989
- Pharmacokinetics of carboplatin after intraperitoneal administrationCancer Chemotherapy and Pharmacology, 1988